Global Animal Vaccines Market Size, Share & Trends Analysis Report, By Product Type (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal), By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Intellistic Research, the global animal vaccines market estimated at USD 11 billion in 2022 and will expand at a compound annual growth rate (CAGR) of 9.60% from 2023 to 2030. Key players in the animal vaccines market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic animal vaccines market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

ANIMAL VACCINES MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Rising Demand For Attenuated Live Vaccines Driving The Market Growth

The attenuated live vaccines have led to huge market growth. It is the most traditional vaccination method used in the veterinary field. Live vaccines method is also under trial for the development of added applications. This factor leads to the growth of the market. Also, growing strategic developments associated with veterinary-animal vaccines is driving the market.

Side-Effects Of Veterinary Animal Vaccines Restraint The Market Growth

Various effects are related with veterinary animal vaccine products. Local effects such as discomfort and swelling at the vaccination site, reduced appetite and activity, mild fever, sneezing, a snotty nose, and coughing. Thus, these factors restrain the market growth.

How are Segments Performing in the Global Animal Vaccines Market?

Animal Vaccines Product Type Segment Breakdown

According to Intellistic Research, the animal vaccines market by product type is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines

Animal Vaccines Animal Type Segment Breakdown

According to Intellistic Research, based on animal type the market is bifurcated into livestock, and companion

Animal Vaccines Route of Administration Segment Breakdown

According to Intellistic Research, based on route of administration the market is segmented into Subcutaneous, Intramuscular, and Intranasal

Animal Vaccines Geographic Exploration

According to Intellistic Research, North America region is predicted to dominate the market, owing to growing occurrences of livestock & zoonotic diseases, resulting in various animal deaths in this region. Also, improvement in animal health expenditure and presence of leading pharmaceutical companies will increase the region's market growth rate. Other regions competing in the market are Asia-Pacific, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: ANIMAL VACCINES

The competitive landscape of the market is highly fragmented. The significant players rapidly evolve with new strategies to attain a competitive edge and capture significant market share.

• For Instance, in June 2021, the U.K. launched a U.K. Animal Vaccine Manufacturing and Innovation Centre, intending to accelerate the development of vaccine for livestock and to control the spread of viral diseases.

Noticeable Players Functioning in The Global Animal Vaccines Market Include:

• Zoetis

• Ceva Santé Animale

• Merck & Co., Inc.

• Vetoquinol S.A.

• Boehringer Ingelheim Gmbh

• Elanco

• Virbac

• Heska

• Dechra Pharmaceuticals Plc

• Idexx Laboratories, Inc.

KEY BREAKDOWN: ANIMAL VACCINES MARKET

By Product Type:

• Attenuated Live Vaccines

• Inactivated Vaccines

• Subunit Vaccines

• DNA Vaccines

• Recombinant Vaccines

By Animal Type:

• Livestock

• Companion

By Route of Administration:

• Subcutaneous

• Intramuscular

• Intranasal

Geographical Exploration:

• North America

o The USA

o Canada

o Mexico

• Europe

o Germany

o France

o U.K.

o Russia

o Italy

o Spain

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o New Zealand

o Singapore

o Malaysia

o Rest of Asia

• Latin America

o Brazil

o Argentina

o Colombia

o Peru

o Chile

o Venezuela

o Rest of Latin America

• Middle East and Africa

o Saudi Arabia

o UAE

o Egypt

o Kuwait

o South Africa

o Rest of Middle East & Africa

Global Animal Vaccines Market TOC:

1. Research Methodology 
1.1. Global Animal Vaccines Market Snapshot, 2023 and 2030 
1.2. Data Mining 
1.3. Validation 
1.4. Primary Interviews 
1.5. List of Data Sources 
1.6. Future Market Projections 
1.7. Industry Developments and Key Market Events 
2. Executive Summary 
3. Market Overview 
3.1. Market Scope and Definition 
3.2. Market Dynamics 
3.2.1. Drivers 
3.2.2. Restraints 
3.2.3. Opportunity 
3.2.4. Challenges 
3.2.5. Cumulative Impact due to Recent Energy Crisis 
3.2.6. Cumulative Impact due to Nearing Economic Downturn 
3.2.7. Post Covid-19 World Supply & Demand Conditions 
3.2.8. Cumulative Impact of Russia-Ukraine Conflict 
3.2.9. Key Trends 
3.3. Animal Vaccines Market: Value Chain 
3.3.1. List of Raw Material Supplier 
3.3.2. List of Manufacturers 
3.3.3. List of Application 
3.4. Porter Five Force’s Analysis 
3.5. Regulatory and Technology Landscape 
4. Global Animal Vaccines Market Outlook: Forecast (2023 – 2030) 
4.1. Key Highlights 
4.1.1. Market Size and Y-o-Y Growth 
4.1.2. Absolute $ Opportunity 
4.2. Market Size (US$ Mn) Analysis and Forecast 
4.2.1. Current Market Size Forecast, 2023–2030 
4.3. Global Animal Vaccines Market Outlook: Product Type 
4.3.1. Introduction / Key Findings 
4.3.2. Market Size (US$ Mn) and Forecast Product Type, 2023 – 2030 
4.3.2.1. Attenuated Live Vaccines 
4.3.2.2. Inactivated Vaccines 
4.3.2.3. Subunit Vaccines 
4.3.2.4. DNA Vaccines 
4.3.2.5. Recombinant Vaccines 
4.4. Global Animal Vaccines Market Outlook: Animal Type 
4.4.1. Introduction / Key Findings 
4.4.2. Market Size (US$ Mn) and Forecast By Animal Type, 2023 – 2030 
4.4.2.1. Livestock 
4.4.2.2. Companion 
4.5. Global Animal Vaccines Market Outlook: Route of Administration 
4.5.1. Introduction / Key Findings 
4.5.2. Market Size (US$ Mn) and Forecast By Route of Administration, 2023 – 2030 
4.5.2.1. Subcutaneous 
4.5.2.2. Intramuscular 
4.5.2.3. Intranasal 
5. Global Animal Vaccines Market Outlook: Region 
5.1. Key Highlights 
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030 
5.2.1. North America 
5.2.2. Europe 
5.2.3. Asia Pacific 
5.2.4. Latin America 
5.2.5. Middle East & Africa (MEA) 
6. North America Animal Vaccines Market Outlook: Forecast (2023 – 2030) 
6.1. Key Highlights 
6.2. Pricing Analysis 
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022 
6.3.1. By Country 
6.3.2. By Product type 
6.3.3. By Animal Type 
6.3.4. By Route of Administration 
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030 
6.4.1. U.S. 
6.4.2. Canada 
6.4.3. Mexico 
6.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030 
6.5.1. Attenuated Live Vaccines 
6.5.2. Inactivated Vaccines 
6.5.3. Subunit Vaccines 
6.5.4. DNA Vaccines 
6.5.5. Recombinant Vaccines 
6.6. Market Size (US$ Mn) and Forecast By Animal Type, 2023 – 2030 
6.6.1. Livestock 
6.6.2. Companion 
6.7. Market Size (US$ Mn) and Forecast By Route of Administration, 2023 – 2030 
6.7.1. Subcutaneous 
6.7.2. Intramuscular 
6.7.3. Intranasal 
7. Europe Animal Vaccines Market Outlook: Forecast (2023 – 2030) 
7.1. Key Highlights 
7.2. Pricing Analysis 
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030 
7.3.1. By Country 
7.3.2. By Product Type 
7.3.3. By Animal Type 
7.3.4. By Route of Administration 
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030 
7.4.1. Germany 
7.4.2. France 
7.4.3. U.K. 
7.4.4. Russia 
7.4.5. Italy 
7.4.6. Spain 
7.4.7. Rest of Europe 
7.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030 
7.5.1. Attenuated Live Vaccines 
7.5.2. Inactivated Vaccines 
7.5.3. Subunit Vaccines 
7.5.4. DNA Vaccines 
7.5.5. Recombinant Vaccines 
7.6. Market Size (US$ Mn) and Forecast By Animal Type, 2023 – 2030 
7.6.1. Livestock 
7.6.2. Companion 
7.7. Market Size (US$ Mn) and Forecast By Route of Administration, 2023 – 2030 
7.7.1. Subcutaneous 
7.7.2. Intramuscular 
7.7.3. Intranasal 
8. Asia Pacific Animal Vaccines Market Outlook: Forecast (2023 – 2030) 
8.1. Key Highlights 
8.2. Pricing Analysis 
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030 
8.3.1. By Country 
8.3.2. By Product type 
8.3.3. By Animal Type 
8.3.4. By Route of Administration 
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030 
8.4.1. China 
8.4.2. Japan 
8.4.3. India 
8.4.4. South Korea 
8.4.5. Australia 
8.4.6. New Zealand 
8.4.7. Singapore 
8.4.8. Malaysia 
8.4.9. Rest of Asia 
8.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030 
8.5.1. Attenuated Live Vaccines 
8.5.2. Inactivated Vaccines 
8.5.3. Subunit Vaccines 
8.5.4. DNA Vaccines 
8.5.5. Recombinant Vaccines 
8.6. Market Size (US$ Mn) and Forecast By Animal Type, 2023 – 2030 
8.6.1. Livestock 
8.6.2. Companion 
8.7. Market Size (US$ Mn) and Forecast By Route of Administration, 2023 – 2030 
8.7.1. Subcutaneous 
8.7.2. Intramuscular 
8.7.3. Intranasal 
9. Latin America Animal Vaccines Market Outlook: Forecast (2023 – 2030) 
9.1. Key Highlights 
9.2. Pricing Analysis 
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030 
9.3.1. By Country 
9.3.2. By Product type 
9.3.3. By Animal Type 
9.3.4. By Route of Administration 
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030 
9.4.1. Brazil 
9.4.2. Argentina 
9.4.3. Colombia 
9.4.4. Peru 
9.4.5. Chile 
9.4.6. Venezuela 
9.4.7. Rest of Latin America 
9.5. Market Size (US$ Mn) and Forecast By Product Type, 2023 – 2030 
9.5.1. Attenuated Live Vaccines 
9.5.2. Inactivated Vaccines 
9.5.3. Subunit Vaccines 
9.5.4. DNA Vaccines 
9.5.5. Recombinant Vaccines 
9.6. Market Size (US$ Mn) and Forecast By Animal Type, 2023 – 2030 
9.6.1. Livestock 
9.6.2. Companion 
9.7. Market Size (US$ Mn) and Forecast By Route of Administration, 2023 – 2030 
9.7.1. Subcutaneous 
9.7.2. Intramuscular 
9.7.3. Intranasal 
10. Middle East & Africa Animal Vaccines Market Outlook: Forecast (2023 – 2030) 
10.1. Key Highlights 
10.2. Pricing Analysis 
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030 
10.3.1. By Country 
10.3.2. By Product type 
10.3.3. By Animal Type 
10.3.4. By Route of Administration 
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030 
10.4.1. Saudi Arabia 
10.4.2. UAE 
10.4.3. Egypt 
10.4.4. Kuwait 
10.4.5. South Africa 
10.4.6. Rest of Middle East & Africa 
10.5. Market Size (US$ Mn) and Forecast By Product type, 2023 – 2030 
10.5.1. Attenuated Live Vaccines 
10.5.2. Inactivated Vaccines 
10.5.3. Subunit Vaccines 
10.5.4. DNA Vaccines 
10.5.5. Recombinant Vaccines 
10.6. Market Size (US$ Mn) and Forecast By Animal Type, 2023 – 2030 
10.6.1. Livestock 
10.6.2. Companion 
10.7. Market Size (US$ Mn) and Forecast By Route of Administration, 2023 – 2030 
10.7.1. Subcutaneous 
10.7.2. Intramuscular 
10.7.3. Intranasal 
11. Competition Analysis 
11.1. Market Share Analysis Of Top Vendors 
11.2. Market Structure 
11.2.1. Competition Intensity Mapping By Market 
11.2.2. Competition Dashboard 
11.2.3. Key Development Strategies 
11.3. Company Profiles 
11.3.1. Zoetis 
11.3.1.1. Overview 
11.3.1.2. Offerings 
11.3.1.3. Business Segment & Geographic Overview 
11.3.1.4. Key Financials 
11.3.1.5. Key Market Developments 
11.3.1.6. Key Market Strategy 
11.3.2. Ceva Santé Animale 
11.3.3. Merck & Co., Inc. 
11.3.4. Vetoquinol S.A. 
11.3.5. Boehringer Ingelheim Gmbh 
11.3.6. Elanco 
11.3.7. Virbac 
11.3.8. Heska 
11.3.9. Dechra Pharmaceuticals Plc 
11.3.10. Idexx Laboratories, Inc.